Cantargia develops antibody based therapies against the target IL1RAP. The two clinical programs are nadunolimab in phase II development for treatment of cancer, and CAN10 in phase I development for autoimmune/inflammatory diseases.
View Top Employees from Cantargia AB| Website | http://www.cantargia.com |
| Ticker | CANTA |
| Revenue | $1 million |
| Employees | 33 (33 on RocketReach) |
| Founded | 2010 |
| Address | Scheelevägen 27, Lund, Skåne County 22363, SE |
| Phone | +46 46 275 62 60 |
| Technologies |
JavaScript,
HTML,
Twitter
+16 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Drug Discovery, Medical Device, Health Care, Therapeutics |
| Web Rank | 11 Million |
| Keywords | Göran Forsberg, Cantargia, Cantargia Mechanism Of Action, Cantargia Ab Prospekt, Camilla Rydberg Millrud Cantargia |
| Competitors | Angiochem, Diffusion Pharmaceuticals, ImmunoCellular Therapeutics Ltd, OxThera, Patrys Limited |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Cantargia AB employee's phone or email?
Cantargia AB Questions
The Cantargia AB annual revenue was $1 million in 2024.
Bengt Jöndell is the CFO of Cantargia AB.
33 people are employed at Cantargia AB.
Cantargia AB is based in Lund, Skåne County.
The NAICS codes for Cantargia AB are [541713, 54171, 5417, 54, 541].
The SIC codes for Cantargia AB are [873, 87].
Top Cantargia AB Employees
-
2
-
4
-
1
-
5+
Related Companies
